by Dr Suvadip Chakrabarti | Jul 21, 2026 | Oncology
Stomach cancer, also known as gastric cancer, develops when malignant cells form within the inner mucosal lining of the stomach. As early-stage gastric malignancies frequently present with mild, non-specific gastrointestinal distress, the disease is regularly...
by Dr Suvadip Chakrabarti | Jul 14, 2026 | Breast Cancer
Fear of recurrence is a major emotional challenge after initial cancer treatment. When breast cancer cells reappear after a period of undetectable disease, it is clinically termed a recurrence. Prompt detection and advanced staging radically alter survival outcomes....
by Dr Suvadip Chakrabarti | Jun 25, 2026 | Oncology
An “inoperable” cancer diagnosis is not always permanent. In some patients, treatment response, reassessment, or improved overall condition can change whether surgery becomes possible later. Modern cancer care now focuses not only on removing tumours, but also...
by Dr Suvadip Chakrabarti | Jun 15, 2026 | Oncology
A stage 4 cancer diagnosis no longer automatically means all treatment options are exhausted. Advances in immunotherapy, targeted therapy, robotic oncology, molecular profiling, and precision radiation have significantly changed how many advanced cancers are managed...
by Dr Suvadip Chakrabarti | May 27, 2026 | Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype that lacks common hormone and HER2 targets, making treatment more complex. It grows faster, has a higher recurrence risk, and requires carefully planned therapies. Advances in treatment are improving...
